Skip to main content

Charles Moore

Analyst

Baird

Equibles does not estimate personal net worth.

About Charles Moore

Charles Moore is recorded as Analyst at Baird. Charles Moore has spoken on 2 earnings calls across 1 company, most recently for Denali Therapeutics Inc. on November 3, 2026. The companies whose calls Charles Moore spoke on are classified in the Healthcare sector.

Charles Moore on recent calls

“I was just curious how you're handling background A-beta treatment, and more generally, how you're thinking about combinability there.”
Analyst — Baird, Third Quarter 2026 Financial Results and Business Highlights ·
“Can we assume that growth trajectory to continue through the end of the year? And could we see maybe OPEX guidance in the future? Thank you.”
Analyst — Baird, Denali Therapeutics Inc. Q2 FY2026 Earnings Call ·

Affiliation history

  • Baird

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity